Application of Clonality Assays in Differential Diagnosis Between Hepatocellular Adenoma and Focal Nodular Hyperplasia

GONG Li,SU Qin,ZHANG Hong-tu,ZHANG Wei,LIU Shan,LI Ai-ning,LI Gang,FENG Ying-ming
DOI: https://doi.org/10.3969/j.issn.1001-7399.2006.04.007
2006-01-01
Experimental Pathology
Abstract:Purpose To elucidate the clonality status of hepatocellular adenoma(HA)and focal nodular hyperplasia(FNH), and to provide a parameter for their differential diagnosis. Methods Two HAs, 4 FNH lesions from 3 women, as well as 4 hepatocellular carcinomas(HCC)were examined by assays based on X-chromosomal inactivation mosiacism. Genomic DNA was isolated from the lesions and the surrounding liver parenchyma, pretreated with the methylation-sensitive restriction enzyme Hpa Ⅱ or Hha Ⅰ, and amplified via nested PCR for phosphoglycerate kinase(PGK)and androgen receptor(AR)genes. The single nucleotide polymorphism at PGK locus was identified by incubation with Bst XI and agarose gel electrophoresis- and the CAG repeat length polymorphism at AR locus was revealed on denaturing polyacrylamide gels and visualized by silver staining.Results HA lesions were composed of cells arranged in 2-cell-thick plates, with focal fatty change and excessive glycogen storage. The tumor cells were round or polygonal, apparently resembling the surrounding liver parenchymal cells in size and shape. Mitosis was not found. Loss of X-chromosomal inactivation mosiacism was demonstrated in both of the 2 HA and 4 HCC lesions examined, reflecting their neoplastic nature. The central stellate scar was not detected in all of the 4 FNH lesions examined, and the assay showed polyclonality in all of them. Conclusions HA is a monoclonal, neoplastic lesion. For its diagnosis, FNH and well-differentiated HCC should be excluded. In addition to histological parameters, clonality assays is useful particularly for its distinction from the FNH lesions without typical histopathological features.
What problem does this paper attempt to address?